Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Clinical trial NCT06890429 · COMPLETED

Trial details

NCT number: NCT06890429
Sponsor: Research Institute of Influenza, Russia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Synctial Virus Infections

Start date: 2023-12-07
Primary completion: 2024-01-08
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.